Cargando…
Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer
BACKGROUND: Ovarian cancer is the most common gynecological malignancy and is difficult to manage due to the emergence of resistance to various chemotherapeutic drugs. New efforts are urgently awaited. Aspirin, which is traditionally considered a nonsteroidal anti-inflammatory drug (NSAID), has been...
Autores principales: | Guo, Jianfeng, Zhu, Yapei, Yu, Lili, Li, Yuan, Guo, Jing, Cai, Jing, Liu, Lin, Wang, Zehua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340904/ https://www.ncbi.nlm.nih.gov/pubmed/34414020 http://dx.doi.org/10.7717/peerj.11591 |
Ejemplares similares
-
Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation
por: Tang, Guiju, et al.
Publicado: (2018) -
Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC
por: Tang, Zuxiong, et al.
Publicado: (2021) -
FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer
por: Zhu, Wei, et al.
Publicado: (2023) -
Prognostic Value and Implication for Chemotherapy Treatment of ABCB1 in Epithelial Ovarian Cancer: A Meta-Analysis
por: Sun, Si, et al.
Publicado: (2016) -
Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair
por: Xiao, Man, et al.
Publicado: (2017)